News, views and contacts from the global Drugdevelopment industry

Today on Drug Development Technology

Orbactiv (oritavancin) for Treatment of Acute Bacterial Skin and Skin Structure Infections

Orbactiv (oritavancin) is the first and only approved antibiotic for the treatment of acute bacterial skin and skin structure infections...

Zinbryta (daclizumab) for the Treatment of Multiple Sclerosis

Zinbryta (daclizumab) is an injectable formulation jointly developed by Biogen and Abbive for the treatment of relapsing forms of...

Idelvion for the Treatment of Haemophilia B

Idelvion (Coagulation Factor IX (Recombinant), Albumin Fusion Protein) is an injectable formulation developed by CSL Behring, for the...

Kovaltry (Anti-haemophilic Factor VII (Recombinant)) for the Treatment of Haemophilia A

Kovaltry (Anti haemophilic Factor VII (Recombinant)) is developed by Bayer as the treatment for children and adult patients with...


Latest Suppliers

Kemwell
Kemwell has been providing CDMO services to pharmaceutical and biopharmaceutical clients globally for more than three decades. Kemwell scientists are specialists in dosage form...
See all suppliers

Latest Products & Services

Malvern Instruments
Zetasizer AT for DLS
Malvern's Zetasizer AT brings the industry leading Dynamic Light Scattering (DLS) technology of the Zetasizer Nano to the process development and manufacturing arena, enabling real...
See all products

cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115